Additionally, multiple KDM2A and KDM2B studies have demonstrated that miR-663a, miR-302a, and miR-let-7b downregulation resulted in the tumorigenesis of GBM and glioma [94,95,96]. This evidence concerns the gene KDM2B and central nervous system cancer.